Henan Lingrui Pharmaceutical Co Ltd (600285) — Cash Flow Reinvestment Rate
Henan Lingrui Pharmaceutical Co Ltd (600285) has a Cash Flow Reinvestment Rate of 0.04x as of September 2025, reinvesting CN¥5.61 Million (capex CN¥5.61 Million ) from operating cash flow of CN¥140.12 Million. See 600285 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Henan Lingrui Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Henan Lingrui Pharmaceutical Co Ltd across 26 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Henan Lingrui Pharmaceutical Co Ltd.
Annual Cash Flow Reinvestment Rate for Henan Lingrui Pharmaceutical Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Henan Lingrui Pharmaceutical Co Ltd. See Henan Lingrui Pharmaceutical Co Ltd (600285) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | CN¥100.28 Million | CN¥553.88 Million | CN¥56.83 Million | ▼ -1.5% |
| 2024 | 0.18x | CN¥160.97 Million | CN¥875.86 Million | CN¥115.11 Million | ▼ -40.4% |
| 2023 | 0.31x | CN¥250.90 Million | CN¥813.43 Million | CN¥21.20 Million | ▲ +132.4% |
| 2022 | 0.13x | CN¥110.81 Million | CN¥834.91 Million | CN¥26.99 Million | ▼ -80.0% |
| 2021 | 0.66x | CN¥559.89 Million | CN¥845.69 Million | CN¥76.91 Million | ▲ +102.2% |
| 2020 | 0.33x | CN¥147.49 Million | CN¥450.53 Million | CN¥71.82 Million | ▼ -32.2% |
| 2019 | 0.48x | CN¥217.21 Million | CN¥450.15 Million | CN¥59.04 Million | ▼ -21.7% |
| 2018 | 0.62x | CN¥268.93 Million | CN¥436.25 Million | CN¥52.14 Million | ▼ -76.2% |
| 2017 | 2.59x | CN¥274.71 Million | CN¥105.97 Million | CN¥257.55 Million | ▼ -33.6% |
| 2016 | 3.90x | CN¥246.94 Million | CN¥63.26 Million | CN¥218.05 Million | ▲ +431.7% |
| 2015 | 0.73x | CN¥115.12 Million | CN¥156.82 Million | CN¥84.23 Million | ▼ -10.6% |
| 2014 | 0.82x | CN¥102.10 Million | CN¥124.32 Million | CN¥102.10 Million | ▼ -37.4% |
| 2013 | 1.31x | CN¥166.88 Million | CN¥127.27 Million | CN¥166.88 Million | ▼ -79.9% |
| 2012 | 6.51x | CN¥100.53 Million | CN¥15.43 Million | CN¥100.53 Million | ▲ +312.7% |
| 2011 | 1.58x | CN¥63.90 Million | CN¥40.49 Million | CN¥63.90 Million | ▲ +364.2% |
| 2009 | 0.34x | CN¥45.08 Million | CN¥132.61 Million | CN¥45.08 Million | ▼ -55.8% |
| 2008 | 0.77x | CN¥33.63 Million | CN¥43.72 Million | CN¥33.63 Million | ▼ -72.6% |
| 2007 | 2.81x | CN¥44.84 Million | CN¥15.99 Million | CN¥44.84 Million | ▲ +353.4% |
| 2006 | 0.62x | CN¥16.56 Million | CN¥26.76 Million | CN¥16.56 Million | ▲ +8.0% |
| 2005 | 0.57x | CN¥19.15 Million | CN¥33.43 Million | CN¥19.15 Million | ▼ -50.0% |
| 2004 | 1.14x | CN¥40.65 Million | CN¥35.51 Million | CN¥40.65 Million | ▼ -33.3% |
| 2003 | 1.72x | CN¥40.81 Million | CN¥23.79 Million | CN¥40.81 Million | ▲ +120.3% |
| 2002 | 0.78x | CN¥54.06 Million | CN¥69.41 Million | CN¥54.06 Million | ▼ -92.9% |
| 2001 | 10.93x | CN¥37.29 Million | CN¥3.41 Million | CN¥37.29 Million | ▲ +6.1% |
| 2000 | 10.31x | CN¥37.76 Million | CN¥3.66 Million | CN¥37.76 Million | ▲ +778.6% |
| 1999 | 1.17x | CN¥5.64 Million | CN¥4.81 Million | CN¥5.64 Million | — |